CIK 0001737287 · Non-accelerated filer<br>Smaller reporting company
Allogene Therapeutics, Inc.
Sign in to watch- Ticker
- ALLO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 823562771
- Phone
- (650) 457-2700
- Business address
- 210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $111,656
- in 2 filings
Net −$111,656. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-10-15 | Belldegrun Arie Director | Conversion | +5,989,352 | 5,989,352 | ||
| 2018-10-15 | Belldegrun Arie Director | Conversion | +1,497,336 | 1,497,336 | ||
| 2018-10-15 | Belldegrun Arie Director | Conversion · Series A Convertible Preferred Stock | −27,095 | 0 | ||
| 2018-10-15 | Belldegrun Arie Director | Conversion · Series A Convertible Preferred Stock | −1,140,829 | 0 | ||
| 2018-10-15 | Belldegrun Arie Director | Conversion · Series A Convertible Preferred Stock | −285,207 | 0 | ||
| 2018-10-15 | TPG Group Holdings (SBS) Advisors, Inc. 10% owner | Conversion | +22,460,061 | 22,460,061 | ||
| 2018-10-15 | TPG Group Holdings (SBS) Advisors, Inc. 10% owner | Purchase | +675,000 | $18.00 | $12.2M | 23,135,061 |
| 2018-10-15 | TPG Group Holdings (SBS) Advisors, Inc. 10% owner | Conversion · Series A Preferred Stock | −4,278,107 | 0 | ||
| 2018-10-15 | PFIZER INC 10% owner | Conversion | +21,976,484 | 21,976,484 | ||
| 2018-10-15 | PFIZER INC 10% owner | Purchase | +55,556 | $18.00 | $1.0M | 22,032,040 |
| 2018-10-15 | PFIZER INC 10% owner | Conversion · Series A-1 Convertible Preferred Stock | −4,185,997 | 0 |
Page 23 of 23 · 451 trades